))
Androgen may be a major factor fueling breast cancer
Archived series ("Inactive feed" status)
When?
This feed was archived on August 21, 2018 01:38 (
Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 53132340 series 55715
Content provided by Insidermedicine Daily News (Video). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Insidermedicine Daily News (Video) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
(April 11, 2013 - Insidermedicine)
From Colorado – A new report presented at the AACR annual meeting identifies androgen as a major factor driving breast cancer. Researchers reviewed breast cancer registries and found that cancers with a higher ratio of androgen receptor to estrogen receptor relapsed faster after receiving anti-estrogen therapy. Researchers then tested the anti-androgen drug enzalutamide in the laboratory on cell lines and found that the therapy had a positive result comparable to tamoxifen.
2469 episodes
Share
